logo-loader

Infinity Pharmaceuticals Inc.

Receive alerts
Market:
NASDAQ
Market Cap:
$71.86 m
Price
1.26 USD
Change
1.61%
52 weeks high
1.94
52 weeks low
0.83

In brief

Infinity Pharmaceuticals, Inc. (IPI) is a drug discovery and development company. The Company’s lead product candidate, IPI-504 (retaspimycin hydrochloride), is an intravenously administered small molecule inhibitor of heat shock protein 90 (Hsp90).